BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2020 10:52:51 AM | Browse: 616 | Download: 910
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 57211
Country/Territory United States
Received
2020-06-03 01:42
Peer-Review Started
2020-06-03 01:43
To Make the First Decision
Return for Revision
2020-06-15 18:17
Revised
2020-07-02 21:13
Second Decision
2020-09-08 12:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-09-08 20:30
Articles in Press
2020-09-08 20:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-09-25 05:13
Publish the Manuscript Online
2020-09-25 10:52
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
Manuscript Source Invited Manuscript
All Author List Sungjin Kim, Timothy P DiPeri, Michelle Guan, Veronica R Placencio-Hickok, Haesoo Kim, Jar-Yee Liu, Andrew Hendifar, Samuel J Klempner, Ryan Nipp, Alexandra Gangi, Miguel Burch, Kevin Waters, May Cho, Joseph Chao, Katelyn Atkins, Mitchell Kamrava, Richard Tuli and Jun Gong
ORCID
Author(s) ORCID Number
Sungjin Kim http://orcid.org/0000-0002-1150-703X
Timothy P DiPeri http://orcid.org/0000-0003-1190-1640
Michelle Guan http://orcid.org/0000-0003-3285-2120
Veronica R Placencio-Hickok http://orcid.org/0000-0002-0463-8867
Haesoo Kim http://orcid.org/0000-0002-7821-264X
Jar-Yee Liu http://orcid.org/0000-0003-0448-2978
Andrew Hendifar http://orcid.org/0000-0002-2079-9177
Samuel J Klempner http://orcid.org/0000-0002-4062-0808
Ryan Nipp http://orcid.org/0000-0002-4577-3248
Alexandra Gangi http://orcid.org/0000-0002-9512-7973
Miguel Burch http://orcid.org/0000-0001-5357-0718
Kevin Waters http://orcid.org/0000-0003-3828-8647
May Cho http://orcid.org/0000-0003-3445-6690
Joseph Chao http://orcid.org/0000-0002-1809-504X
Katelyn Atkins http://orcid.org/0000-0002-3165-4803
Mitchell Kamrava http://orcid.org/0000-0003-1744-6271
Richard Tuli http://orcid.org/0000-0002-3525-687X
Jun Gong http://orcid.org/0000-0001-8713-1406
Funding Agency and Grant Number
Corresponding Author Jun Gong, MD, Assistant Professor, Department of Medicine, Division of Hematology and Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, 8700 Beverly Blvd, AC 1042B, Los Angeles, CA 90048, United States. jun.gong@cshs.org
Key Words Esophageal cancer; Metastatic; Palliative; Chemotherapy; Radiotherapy; Survival
Core Tip We evaluated the impact of non-chemotherapy-based palliative treatments in patients with metastatic esophageal cancer not receiving chemotherapy. A remarkably small fraction of these patients does not receive any palliative therapy. These findings merit further investigation to identify those at greatest risk who may benefit from risk-tailored management approaches. There was a numerically higher but not statistically significant difference in overall survival among those who received other palliative therapies vs those who did not (median overall survival 2.83 mo vs 2.37 mo). Our analysis was limited by lack of ability to account for patients at different stages of presentation or severity of disease.
Publish Date 2020-09-25 10:52
Citation Kim S, DiPeri TP, Guan M, Placencio-Hickok VR, Kim H, Liu JY, Hendifar A, Klempner SJ, Nipp R, Gangi A, Burch M, Waters K, Cho M, Chao J, Atkins K, Kamrava M, Tuli R, Gong J. Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World J Gastrointest Surg 2020; 12(9): 377-389
URL https://www.wjgnet.com/1948-9366/full/v12/i9/377.htm
DOI https://dx.doi.org/10.4240/wjgs.v12.i9.377
Full Article (PDF) WJGS-12-377.pdf
Full Article (Word) WJGS-12-377.docx
Manuscript File 57211-Review.docx
Answering Reviewers 57211-Answering reviewers.pdf
Audio Core Tip 57211-Audio core tip.m4a
Biostatistics Review Certificate 57211-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 57211-Conflict-of-interest statement.pdf
Copyright License Agreement 57211-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 57211-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 57211-Institutional review board statement.pdf
Peer-review Report 57211-Peer-review(s).pdf
Scientific Misconduct Check 57211-Scientific misconduct check.pdf
Scientific Editor Work List 57211-Scientific editor work list.pdf